QUINTON BIJOU: Open Payments
NPI 1154728392 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,669 in 74 payments from 17 companies in 2025. Trend: 2023 $1,463 · 2024 $1,327 · 2025 $2,669
Food & beverage: $1,817Travel & lodging: $852
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 20 | $1,525 |
| Novartis Pharmaceuticals Corporation | 17 | $243 |
| Alnylam Pharmaceuticals Inc. | 3 | $155 |
| Boston Scientific Corporation | 5 | $116 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $116 |
| Novo Nordisk Inc | 4 | $88 |
| Merck Sharp & Dohme LLC | 5 | $87 |
| Kestra Medical Technology Services, Inc. | 2 | $76 |
| Tactile Systems Technology Inc | 2 | $52 |
| Amgen Inc. | 3 | $47 |
Products named: CARDIOMEMS, LEQVIO, AMVUTTRA, LifeVest, Assure WCD, JOT DX, VERQUVO, Wegovy.
Industry payments across TX — which companies pay providers there.
